Osteoarthritis Therapeutics Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Osteoarthritis Therapeutics Market - By Anatomy (Knee, Hip, Hand, Small Joints) By Drug type (Viscosupplementation Agents, Nonsteroidal, Analgesics, Corticosteroids) By Route of Administration (Parenteral, Topical, Oral) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Purchasing Pattern (Prescription Drug, Over-the-counter Drug) By Region (North America, Europe, Asia Pacific, Rest of the World) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 194

Status: Published

Report Code: EMR100595

The osteoarthritis therapeutics market is expected to grow from USD 7.3 billion in 2020 to reach USD 13.1 billion by 2027, at a CAGR of 8.7 %. This industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease.

Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. Osteoarthritis is the most common form of arthritis which causes pain, swelling, and reduced motion in the joints. Usually, osteoarthritis affected joints are inclusive of hands, knees, hips and spine. Osteoarthritis breaks the cartilage of the joints which is a slippery tissue covering the ends of bones in a joint. Geriatric population and over-weighted individuals are at higher risks of osteoarthritis The availability of advanced diagnostic modalities such as magnetic resonance imaging (MRI) and imaging biomarkers have helped in addressing the efficacy of novel drugs for osteoarthritis treatment. MRI is increasingly replacing X-ray imaging techniques for the visualization of articular cartilage and intra-articular structures. The use of imaging biomarkers is also increasing in the identification of biosignals, which helps in predicting the response to NSAIDs in osteoarthritis patients. The development of imaging biomarkers based on radiographic features such as Kellgren-Lawrence will further boost its adoption in osteoarthritis treatment. The availability of improved diagnostic modalities will be one of the significant factors driving osteoarthritis therapeutics market growth.

Extensive research and development have helped in understanding molecular pathways and identifying drug targets for osteoarthritis treatment. This has subsequently aided the development of analgesic drugs, which can selectively target most of the pathways such as G-protein coupled receptors and voltage-sensitive calcium channels. Disease-modifying drugs are also under development, which focuses on proinflammatory cytokines responsible for cartilage breakdown in osteoarthritis. In addition to the availability of improved diagnostic modalities, the expanding research and development activities will also contribute to the growth of the osteoarthritis therapeutics market. As a result, the market will register at a CAGR of almost 9% during the forecast period.

The prominent players operating in this market include Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), Novartis (Switzerland), Bioventus (US) Zimmer Biomet Holdings, Inc.(US), Flexion Therapeutics (US) and FidiaFarmaceuticis.p.a. (Italy).

Sanofi (France) is one of the leading players in the market in 2018. The company boasts of a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the market.

Analyst Commentary

This industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.

Based on anatomy, the knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis.

Based on drug drug type, the viscosupplementation agents segment accounted for the largest market share in 2018. The rising incidence and prevalence of knee osteoarthritis are supporting their adoption in the market.

Segmentation

The osteoarthritis therapeutics market is segmented on the basis of anatomy, drug drug type, route of administration, distribution channel, purchasing pattern and region. Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. Based on drug drug type, the market is segmented into viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. Based on route of administration Parenteral, Topical, Oral. Based on distribution channel the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Based on purchasing pattern Prescription Drug, Over-the-counter Drug.

Regional Analysis

America dominates the global osteoarthritis market owing to a well-developed healthcare sector and huge patient population for osteoarthritis. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America

Europe is the second largest osteoarthritis market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the market growth during the forecasted period. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe hold the major share of the regional market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest growing region due the huge opportunities in the untapped market.

Asia Pacific is the fastest growing region in global the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market.. Moreover, favourable government policies and increasing healthcare expenditures fuels the market growth within the region.

On the other hand, the Middle East & Africa holds the least share in the global osteoarthritis market due to presence of poor economy, especially, in African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai and Qatar.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Osteoarthritis Therapeutics Market
Chapter 5. Global Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
5.1. Global Osteoarthritis Therapeutics Market Share, By Drug Type, 2015 - 2027 (USD Billion)
5.1.1. Visco supplementation agents
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Nonsteroidal anti-inflammatory drugs
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Analgesics
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Corticosteroids
5.1.4.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
6.1. Global Osteoarthritis Therapeutics Market Share, By Route of Administration, 2015 - 2027 (USD Billion)
6.1.1. Parenteral
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Topical
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Oral
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Others
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Osteoarthritis Therapeutics Market Overview, By Distribution Channel, 2015 - 2027(USD Billion)
7.1. Global Osteoarthritis Therapeutics Market Share, By Distribution Channel, 2015 - 2027 (USD Billion)
7.1.1. Hospital pharmacies
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Retail pharmacies
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.3. Online pharmacies
7.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.4. Others
7.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern, 2015 - 2027(USD Billion)
8.1. Global Osteoarthritis Therapeutics Market Share, By Purchasing Pattern, 2015 - 2027 (USD Billion)
8.1.1. Prescription drug
8.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
8.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
8.1.2. Over-the-counter drug
8.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
8.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 9. Global Osteoarthritis Therapeutics Market Overview, By Anatomy, 2015 - 2027(USD Billion)
9.1. Global Osteoarthritis Therapeutics Market Share, By Anatomy, 2015 - 2027 (USD Billion)
9.1.1. knee
9.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
9.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
9.1.2. Hip
9.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
9.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
9.1.3. Hand
9.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
9.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
9.1.4. Small joint
9.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
9.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 10. Global Osteoarthritis Therapeutics Market Overview, By Geography, 2015 - 2027(USD Billion)
10.1. Global Osteoarthritis Therapeutics Market Share, By Geography, 2015 - 2027(USD Billion)
10.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Billion)
10.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 11. North America Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027(USD Billion)
11.1. North America Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.2. North America Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
11.1.3. North America Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.4. North America Osteoarthritis Therapeutics Market Overview, By Distribution Channel,2015 - 2027 (USD Billion)
11.1.5. North America Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern,2015 - 2027 (USD Billion)
11.1.6. North America Osteoarthritis Therapeutics Market Overview, By Anatomy,2015 - 2027 (USD Billion)
11.1.7. North America Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.7.1. U.S. Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
11.1.7.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.7.1.2. U.S. Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
11.1.7.1.3. U.S. Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.7.1.4. Other Segment
11.1.7.2. Canada Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
11.1.7.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.7.2.2. Canada Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
11.1.7.2.3. Canada Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.7.2.4. Other Segment
11.1.7.3. Mexico Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
11.1.7.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.7.3.2. Mexico Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
11.1.7.3.3. Mexico Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.7.3.4. Other Segment
Chapter 12. Europe Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1. Europe Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.2. Europe Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
12.1.3. Europe Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
12.1.4. Europe Osteoarthritis Therapeutics Market Overview, By Distribution Channel,2015 - 2027 (USD Billion)
12.1.5. Europe Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern,2015 - 2027 (USD Billion)
12.1.6. Europe Osteoarthritis Therapeutics Market Overview, By Anatomy,2015 - 2027 (USD Billion)
12.1.7. Europe Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.7.1. Germany
12.1.7.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.7.1.2. Germany Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.1.3. Germany Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
12.1.7.1.4. Other Segments
12.1.7.2. France
12.1.7.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.7.2.2. France Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.2.3. France Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
12.1.7.2.4. Other Segments
12.1.7.3. UK
12.1.7.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.7.3.2. UK Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.3.3. UK Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
12.1.7.3.4. Other Segments
12.1.7.4. Italy
12.1.7.4.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.7.4.2. Italy Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.4.3. Italy Osteoarthritis Therapeutics Market Overview, By Route of Administration2015 - 2027(USD Billion)
12.1.7.4.4. Other Segments
12.1.7.5. Spain
12.1.7.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.7.5.2. Spain Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.5.3. Spain Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
12.1.7.5.4. Other Segments
12.1.7.6. Rest of Europe
12.1.7.6.1. Market Type and projections, 2015 – 2027
12.1.7.6.2. Rest of Europe Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
12.1.7.6.3. Rest of Europe Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
12.1.7.6.4. Other Segments
Chapter 13. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. Asia Pacific Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.2. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
13.1.3. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.4. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Distribution Channel,2015 - 2027 (USD Billion)
13.1.5. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern,2015 - 2027 (USD Billion)
13.1.6. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Anatomy,2015 - 2027 (USD Billion)
13.1.7. Asia Pacific Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1.7.1. India
13.1.7.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.1.2. India Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
13.1.7.1.3. India Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.7.1.4. Other Segments
13.1.7.2. China
13.1.7.2.1. Market Type and projections, 2015 - 2027(USD Billion)
13.1.7.2.2. China Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
13.1.7.2.3. China Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.7.2.4. Other Segments
13.1.7.3. Japan
13.1.7.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.3.2. Japan Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
13.1.7.3.3. Japan Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
13.1.7.3.4. Other Segments
13.1.7.4. South Korea
13.1.7.4.1. Market Type and projections, 2015 - 2027(USD Billion)
13.1.7.4.2. South Korea Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
13.1.7.4.3. South Korea Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.7.4.4. Other Segments
13.1.7.5. Rest of Asia Pacific
13.1.7.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.5.2. Rest of Asia Pacific Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027(USD Billion)
13.1.7.5.3. Rest of Asia Pacific Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.7.5.4. Other Segments
Chapter 14. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
14.1. Middle East & Africa Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
14.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
14.1.2. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
14.1.3. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
14.1.4. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Distribution Channel,2015 - 2027 (USD Billion)
14.1.5. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern,2015 - 2027 (USD Billion)
14.1.6. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Anatomy,2015 - 2027 (USD Billion)
14.1.7. Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
14.1.7.1. GCC
14.1.7.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
14.1.7.1.2. GCC Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
14.1.7.1.3. GCC Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
14.1.7.1.4. Other Segments
14.1.7.2. South Africa
14.1.7.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
14.1.7.2.2. South Africa Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
14.1.7.2.3. South Africa Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
14.1.7.2.4. Other Segments
14.1.7.3. Rest of Middle East & Africa
14.1.7.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
14.1.7.3.2. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
14.1.7.3.3. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
14.1.7.3.4. Other Segments
Chapter 15. South America Osteoarthritis Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
15.1. South America Osteoarthritis Therapeutics Market Overview, 2015 - 2027 (USD Billion)
15.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
15.1.2. South America Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
15.1.3. South America Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
15.1.4. South America Osteoarthritis Therapeutics Market Overview, By Distribution Channel,2015 - 2027 (USD Billion)
15.1.5. South America Osteoarthritis Therapeutics Market Overview, By Purchasing Pattern,2015 - 2027 (USD Billion)
15.1.6. South America Osteoarthritis Therapeutics Market Overview, By Anatomy,2015 - 2027 (USD Billion)
15.1.7. South America Osteoarthritis Therapeutics Market Overview, By Countries, 2015- 2026 (USD Billion)
15.1.8. Brazil
15.1.8.1. Market Type and projections, 2015 - 2027 (USD Billion)
15.1.8.2. Brazil Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
15.1.8.3. Brazil Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
15.1.8.4. Other Segments
15.1.9. Argentina
15.1.9.1. Market Type and projections, 2015 - 2027 (USD Billion)
15.1.9.2. Argentina Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
15.1.9.3. Argentina Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
15.1.9.4. Other Segments
15.1.10. Rest of South America
15.1.10.1. Market Type and projections, 2015 – 2027
15.1.10.2. Rest of South America Osteoarthritis Therapeutics Market Overview, By Drug Type, 2015 - 2027 (USD Billion)
15.1.10.3. Rest of South America Osteoarthritis Therapeutics Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
15.1.10.4. Other Segments
Chapter 16. Competitive Landscape
16.1. Competitive environment, 2020
16.2. Strategic framework
16.2.1. Partnership/agreement
16.2.2. Expansion
16.2.3. Mergers & Acquisitions
16.2.4. New Technology development
Chapter 17. Key Vendor Analysis
17.1. Sanofi
17.1.1. Company overview
17.1.2. Financial performance
17.1.3. Mice Benchmarking
17.1.4. Recent initiatives
17.1.5. SWOT analysis
17.2. Horizon therapeutics
17.2.1. Company overview
17.2.2. Financial performance
17.2.3. Mice Benchmarking
17.2.4. Recent initiatives
17.2.5. SWOT analysis
17.3. Johnson & Johnson
17.3.1. Company overview
17.3.2. Financial performance
17.3.3. Mice Benchmarking
17.3.4. Recent initiatives
17.4. GlaxoSmithKline
17.5. Bayer AG
Chapter 18. Osteoarthritis Therapeutics Market Cost Analysis
18.1. Osteoarthritis Therapeutics Market Key Technology Analysis
18.1.1. Key Technology
18.1.2. Price Trend of Key Technology
18.1.3. Key Suppliers of Technology
18.1.4. Market Concentration Rate of Technology
18.1.5. Technology
18.1.6. Labor Cost
Chapter 19. Heavy Duty and Bariatric Bags Chain, Sourcing Strategy and Downstream Buyers
19.1. Osteoarthritis Therapeutics Market Heavy Duty and Bariatric Bags Chain Analysis
19.2. Upstream Technology Sourcing
19.3. Technology Sources of Osteoarthritis Therapeutics Market Major Manufacturers in 2020
19.4. Downstream Buyers
Chapter 20. Marketing Strategy Analysis, Distributors/Traders
20.1. Marketing Channel
20.1.1. Direct Marketing
20.1.2. Indirect Marketing
20.1.3. Marketing Channel Development Trend
20.2. Market Positioning
20.2.1. Pricing Strategy
20.2.2. Brand Strategy
20.2.3. Target Client
20.3. Distributors/Traders List
Chapter 21. Market Effect Factors Analysis
21.1. Technology Progress/Risk
21.1.1. Substitutes Threat
21.1.2. Technology Progress in Related Type
21.2. Consumer Needs/Customer Preference Change
21.3. Economic/Political Environmental Change
Chapter 22. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Osteoarthritis Therapeutics Market share, By Drug Type, 2020 & 2027 (%)
10. Global Osteoarthritis Therapeutics Market share, by Visco supplementation agents, By Drug Type, 2015 - 2027 (USD Billion)
11. Global Osteoarthritis Therapeutics Market share, by Nonsteroidal anti-inflammatory drugs, By Drug Type, 2015 - 2027 (USD Billion)
12. Global Osteoarthritis Therapeutics Market share, by Analgesics, By Drug Type, 2015 - 2027 (USD Billion)
13. Global Osteoarthritis Therapeutics Market share, by Corticosteroids, By Drug Type, 2015 - 2027 (USD Billion)
14. Global Osteoarthritis Therapeutics Market share, By Route of Administration, 2020 & 2027 (%)
15. Global Osteoarthritis Therapeutics Market share, by Parenteral, By Route of Administration, 2015 - 2027 (USD Billion)
16. Global Osteoarthritis Therapeutics Market share, by Topical, By Route of Administration 2015 - 2027 (USD Billion)
17. Global Osteoarthritis Therapeutics Market share, by Oral, By Route of Administration 2015 - 2027 (USD Billion)
18. Global Osteoarthritis Therapeutics Market share, by Others, By Route of Administration 2015 - 2027 (USD Billion)
19. Global Osteoarthritis Therapeutics Market share, By Distribution Channel, 2020 & 2027 (%)
20. Global Osteoarthritis Therapeutics Market share, by Hospital pharmacies, By Distribution Channel, 2015 - 2027 (USD Billion)
21. Global Osteoarthritis Therapeutics Market share, by Retail pharmacies, By Distribution Channel 2015 - 2027 (USD Billion)
22. Global Osteoarthritis Therapeutics Market share, by Online pharmacies, By Distribution Channel 2015 - 2027 (USD Billion)
23. Global Osteoarthritis Therapeutics Market share, by Others, By Distribution Channel 2015 - 2027 (USD Billion)
24. Global Osteoarthritis Therapeutics Market share, By Purchasing Pattern, 2020 & 2027 (%)
25. Global Osteoarthritis Therapeutics Market share, by Prescription drug, By Purchasing Pattern, 2015 - 2027 (USD Billion)
26. Global Osteoarthritis Therapeutics Market share, by Over-the-counter drug, By Purchasing Pattern 2015 - 2027 (USD Billion)
27. Global Osteoarthritis therapeutics Market Overview, By Anatomy, 2020 - 2027 (USD Million)
28. Global Osteoarthritis Therapeutics Market share, by knee, By Anatomy 2015 - 2027 (USD Billion)
29. Global Osteoarthritis Therapeutics Market share, by Hip, By Anatomy 2015 - 2027 (USD Billion)
30. Global Osteoarthritis Therapeutics Market share, by Hand, By Anatomy 2015 - 2027 (USD Billion)
31. Global Osteoarthritis Therapeutics Market share, by Small joint, By Anatomy 2015 - 2027 (USD Billion)
32. Global Osteoarthritis Therapeutics Market share, by region, 2020 & 2027 (%)
33. Global Osteoarthritis Therapeutics Market share, by region, 2015 - 2027(USD Billion)
34. North America Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
35. North America Osteoarthritis Therapeutics Market share, by Countries, 2020 & 2027 (%)
36. U.S. Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
37. Canada Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
38. Mexico Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
39. Europe Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
40. Europe Osteoarthritis Therapeutics Market share, by Countries, 2020 & 2027 (%)
41. Spain Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
42. UK Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
43. Italy Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
44. Germany Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
45. France Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
46. Rest of Europe Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
47. Asia-Pacific Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
48. Asia-Pacific Osteoarthritis Therapeutics Market share, by Countries, 2020 & 2027 (%)
49. China Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
50. India Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
51. Australia Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
52. Japan Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
53. Rest of Asia-Pacific Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
54. Middle East & Africa Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
55. Middle East & Africa Osteoarthritis Therapeutics Market share, by Countries, 2020 & 2027 (%)
56. GCC Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
57. South Africa Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
58. Rest Of Middle East & Africa Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
59. South America Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
60. Brazil Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
61. Mexico Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
62. Argentina Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)
63. Rest Of South America Osteoarthritis Therapeutics Market, 2015 - 2027(USD Billion)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Osteoarthritis Therapeutics Market, 2015-2027 (USD Billion)
4. Osteoarthritis Therapeutics requirement, by country, 2015-2027, (USD Billion)
5. North America Osteoarthritis Therapeutics Market, By Drug Type, 2015-2027 (USD Billion)
6. North America Osteoarthritis Therapeutics Market, By Route of Administration, 2015-2027 (USD Billion)
7. North America Osteoarthritis Therapeutics Market, By Distribution Channel, 2015-2027 (USD Billion)
8. North America Osteoarthritis Therapeutics Market, By Purchasing Pattern, 2015-2027 (USD Billion)
9. North America Osteoarthritis Therapeutics Market, By Anatomy, 2015-2027 (USD Billion)
10. Europe Osteoarthritis Therapeutics Market, By Drug Type, 2015-2027 (USD Billion)
11. Europe Osteoarthritis Therapeutics Market, By Route of Administration, 2015-2027 (USD Billion)
12. Europe Osteoarthritis Therapeutics Market, By Distribution Channel, 2015-2027 (USD Billion)
13. Europe Osteoarthritis Therapeutics Market, By Purchasing Pattern, 2015-2027 (USD Billion)
14. Europe Osteoarthritis Therapeutics Market, By Anatomy, 2015-2027 (USD Billion)
15. Asia Pacific Osteoarthritis Therapeutics Market, By Drug Type, 2015-2027 (USD Billion)
16. Asia Pacific Osteoarthritis Therapeutics Market, By Route of Administration, 2015-2027 (Revenue, USD Billion)
17. Asia Pacific Osteoarthritis Therapeutics Market, By Distribution Channel, 2015-2027 (Revenue, USD Billion)
18. Asia Pacific Osteoarthritis Therapeutics Market, By Purchasing Pattern, 2015-2027 (Revenue, USD Billion)
19. Asia Pacific Osteoarthritis Therapeutics Market, By Anatomy, 2015-2027 (Revenue, USD Billion)
20. Middle East & Africa Osteoarthritis Therapeutics Market, By Drug Type, 2015-2027 (USD Billion)
21. Middle East & Africa Osteoarthritis Therapeutics Market, By Route of Administration, 2015-2027 (USD Billion)
22. Middle East & Africa Osteoarthritis Therapeutics Market, By Distribution Channel, 2015-2027 (USD Billion)
23. Middle East & Africa Osteoarthritis Therapeutics Market, By Purchasing Pattern, 2015-2027 (USD Billion)
24. Middle East & Africa Osteoarthritis Therapeutics Market, By Anatomy, 2015-2027 (USD Billion)
25. South America Osteoarthritis Therapeutics Market, By Drug Type, 2015-2027 (USD Billion)
26. South America Osteoarthritis Therapeutics Market, By Route of Administration, 2015-2027 (USD Billion)
27. South America Osteoarthritis Therapeutics Market, By Distribution Channel, 2015-2027 (USD Billion)
28. South America Osteoarthritis Therapeutics Market, By Purchasing Pattern, 2015-2027 (USD Billion)
29. South America Osteoarthritis Therapeutics Market, By Anatomy, 2015-2027 (USD Billion)
30. Global Osteoarthritis Therapeutics Market, Company Market Share, 2020 - 2027 (%)
31. Sanofi: Technology Benchmarking
32. Sanofi : Financial Performance
33. Horizon therapeutics : Technology Benchmarking
34. Horizon therapeutics : Financial Performance
35. Johnson & Johnson : Technology Benchmarking
36. Johnson & Johnson : Financial Performance
37. GlaxoSmithKline :Technology Benchmarking
38. GlaxoSmithKline : Financial Performance
39. Bayer AG : Technology Benchmarking
40. Bayer AG : Financial Performance

The Leading Key Players in Osteoarthritis Therapeutics Market

Sanofi (France)
Horizon Therapeutics (Ireland)
Johnson & Johnson (US)
GlaxoSmithKline Plc (UK)
Bayer AG (Germany)
Abbott (US)
Pfizer (US)
Eli Lilly (US)
Anika Therapeutics (US)
Novartis (Switzerland)
Bioventus (US) Zimmer Biomet Holdings Inc.(US)
Flexion Therapeutics (US) and FidiaFarmaceuticis.p.a. (Italy).